Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.

被引：2
|
作者：
Ferenci, P
Brunner, H
Vogel, W
Gschwantler, M
Datz, C
Hackl, F
Steindl-Munda, PE
Hofer, H
Mueller, C
Mueller, C
机构：
[1] Univ Vienna, Vienna, Austria
[2] Hosp Lainz, Vienna, Austria
[3] Univ Innsbruck, Vienna, Austria
[4] Hosp Rudolfsstiftung, Vienna, Austria
[5] St Johann Hosp, Salzburg, Austria
[6] St Elizabeth Hosp, Linz, Austria
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85986-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：A961 / A961
页数：1
相关论文
共 50 条
  • [31] Effect of 12 month αIFN and Ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Idéo, GM
    Mondazzi, L
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [32] Effect of combination therapy of interferon alpha and ribavirin in the patients with chronic hepatitis C
    Kim, Seok Hyn
    Lee, Byung Seok
    Lee, Heon Young
    Lee, Tae Hee
    Kang, Young Woo
    Park, Jeong Hoon
    Kim, Hong Su
    Kim, Suk Bae
    Song, Il Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A467 - A467
  • [33] Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
    Soza, A
    Everhart, JE
    Ghany, MG
    Doo, E
    Heller, T
    Promrat, K
    Park, Y
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2002, 36 (05) : 1273 - 1279
  • [34] Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Joonho Yoon
    Jong In Lee
    Soon Koo Baik
    Kwang Ho Lee
    Joon Hyung Sohn
    Hyean-Woo Lee
    Jun Namkung
    Sei Jin Chang
    Jong-Whan Choi
    Hyun-Won Kim
    Byung-Il Yeh
    World Journal of Gastroenterology, 2007, (46) : 6236 - 6242
  • [35] Interferon and ribavirin combination therapy for chronic hepatitis C: a family impact study
    Blacklaws, H.
    Veysey, H.
    Skinner, V.
    Sheather-Reid, R.
    Hawken, G.
    Veysey, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A339 - A339
  • [36] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Horiike, N
    Onji, M
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 302 - 304
  • [37] Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Yoon, Joonho
    Lee, Jong In
    Baik, Soon Koo
    Lee, Kwang Ho
    Sohn, Joon Hyung
    Lee, Hyean-Woo
    Namkung, Jun
    Chang, Sei Jin
    Choi, Jong-Whan
    Kim, Hyun-Won
    Yeh, Byung-Il
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6236 - 6242
  • [38] Comparison between IFN induction therapy, IFN induction plus ribavirin and IFN plus ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1:: Final report
    Bellobuono, A
    Tempini, S
    Cattaneo, C
    Grimoldi, D
    Bellobuono, A
    Di Berardino, F
    Idéo, GM
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2001, 34 : 148 - 148
  • [39] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
    Vlodov, J
    Charania, M
    Jose, RM
    Iswara, K
    Lapin, S
    Terebelo, S
    Bernstein, M
    Tenner, S
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [40] A combined therapy with high dose of interferon (IFN)-alpha as an induction and ribavirin in non-responders to IFN alone with chronic hepatitis C
    Takashimizu, S
    Watanabe, N
    Mine, T
    Matsuzaki, S
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
12345